] LG Life Science
announced on Sept. 1 that it is releasing two kinds of fillers containing lidocaine, a local anesthesia, in China.
The biopharmaceutical arm of LG is launching Yvoire Classic Plus and Yvoire Volume Plus, dermal wrinkle fillers equipped with the solution to relieve pain upon administration.
LG has won approval for sales from China Food and Drug Administration in April, the first for an imported filler containing lidocaine.
The South Korean company’s dermal filler range has posted 18.5 billion won (US$16.51 million) in sales in the second quarter of this year, doubling from the same period last year. About 75 percent of the sales came from exports, with China being its main market.
By Hwang You-mee (firstname.lastname@example.org